Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transdermal absorption pharmaceutical composition containing testosterone

A composition and drug technology, applied in the field of pharmaceutical composition, can solve the problem of uncountable combinations

Inactive Publication Date: 2013-03-06
TIANJIN JINYAO GRP
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Transdermal absorption enhancer refers to a material that can penetrate into the skin and reduce the resistance of drugs passing through the skin. It can assist drugs to pass through the stratum corneum, diffuse through the skin, and enter the systemic circulation from capillaries. The effects of skin absorption enhancers are also varied, especially the combination of different types of transdermal absorption enhancers is innumerable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermal absorption pharmaceutical composition containing testosterone
  • Transdermal absorption pharmaceutical composition containing testosterone
  • Transdermal absorption pharmaceutical composition containing testosterone

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0018] The particle size in the following examples refers to the corresponding particle size when the cumulative particle size distribution percentage reaches 90%, which are all measured according to the light scattering method in Appendix 73 of the Chinese Pharmacopoeia 2010 Edition.

[0019] In vitro percutaneous penetration test

[0020] After 3-month-old healthy rats were anesthetized and killed, the abdominal hair was removed with scissors, the uninjured skin was removed, and the subcutaneous tissue was removed. After cleaning, they were respectively fixed at the release port of the Franz diffusion cell, and pH 7.4 was added to the receiving chamber. A mixture of phosphate-buffered saline (PBS), propylene glycol (1:1) and gentamicin sulfate (50 μg / ml) was used as the release medium, and the endothelial layer was kept in close contact with the solution. 10 units of the medicine taken each time were subjected to the permeability test.

[0021] Take 0.1ml of the drug soluti...

Embodiment 1

[0026]

[0027]

[0028] Dissolve the prescribed amount of transdermal absorption enhancer in 400ml of ethanol, dissolve 20g of testosterone (average particle size of 5μm) in 500ml of ethanol, mix the two liquids evenly, filter with No. 3 vertical melting funnel, and wash No. 3 with the remaining ethanol. Vertical melting funnel, above-mentioned preparation is filled in the medicinal spray bottle according to the requirement of testosterone 0.1g / bottle.

[0029] The permeability test was carried out according to the requirements of the above-mentioned in vitro percutaneous penetration test, and the penetration rate of 3h and the cumulative release amount of 12h were obtained. The experimental results proved that the effect of the penetration enhancer mixed with menthol and octyl salicylate was better than that used alone, far better other penetration enhancers.

Embodiment 2

[0031] The average particle size of the drug in this example is 5 μm, and the dosage is equivalent to 20 g of testosterone.

[0032] 90-day stability test:

[0033] The pharmaceutical composition obtained in the examples is stored airtight at 60°C ± 2°C, and the relative humidity is 75% ± 5%, and the stability test is carried out, and the drug content of 5 units is respectively detected on the 0th day and stored until the 90th day , A=average content on day 90 / average content on day 0.

[0034]

[0035]

[0036] Take the prescribed amount of transdermal absorption enhancer and dissolve it in 400ml of liquid alcohol, dissolve the drug in 500ml of liquid alcohol, mix the two liquids evenly, filter with No. 3 vertical melting funnel, wash No. 3 vertical melting funnel with the remaining liquid alcohol, and put The above-mentioned preparation is filled in a medicinal spray bottle according to the requirement of 0.1 g / bottle (equivalent to testosterone) of the drug, and then...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a transdermal absorption pharmaceutical composition containing testosterone. The pharmaceutical composition is composed of male sex hormone used as an active component and one or a plurality of pharmaceutical adjuvants pharmaceutically applicable to a transdermal delivery system. The pharmaceutic adjuvants pharmaceutically applicable to the transdermal delivery system comprise a penetration enhancer and one or a plurality of alcohols which is in a liquid state under normal temperature. The male sex hormone is testosterone, dihydrotestosterone, methyltestosterone, testosterone propionate and testosterone undecanoate, and preferably, testosterone and dihydrotestosterone.

Description

Technical field: [0001] The invention relates to a pharmaceutical composition, which is a transdermal absorption pharmaceutical composition containing testosterone. Background technique: [0002] Testosterone (testosterone, testosterone) is an important steroidal androgen drug, which can promote the development and maturation of male sexual organs and secondary sexual characteristics, resist estrogen, and promote protein synthesis and bone formation. It is decomposed in the body through liver metabolism and cannot play a role, so it is rarely used clinically [0003] Transdermal delivery systems (TDS) refer to controlled-release preparations that are administered through the skin to achieve systemic therapeutic effects. TDS is a very promising dosage form, and its research has become one of the central contents of the development and research of the third generation of pharmaceutical preparations. However, due to the barrier function of the skin and the physical and chemic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/12A61K31/568A61K31/5685A61K47/38A61K47/32A61P5/26
Inventor 孙亮陈松赵琳
Owner TIANJIN JINYAO GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com